Viscosupplementation Market Report 2026

Viscosupplementation Market Overview

• Viscosupplementation market size has reached to $4.5 billion in 2025 • Expected to grow to $7.34 billion in 2030 at a compound annual growth rate (CAGR) of 10.2% • Growth Driver: Osteoarthritis Surge Fuels Viscosupplementation Market Growth • Market Trend: Innovations In Viscosupplementation With Resorbable Hyaluronic Acid Scaffolds For Enhanced Joint Health • North America was the largest region in 2025.

What Is Covered Under Viscosupplementation Market?

Viscosupplementation refers to a process where hyaluronic acid, a fluid that resembles gel, is injected straight into the joint. Synovial fluid around joints naturally contains hyaluronic acid, which helps lessen friction while moving. The main types of viscosupplementation are single-injection viscosupplementation, three-injection viscosupplementation and five-injection viscosupplementation. Single injection viscosupplementation refers to an injection shot of hyaluronic acid that is given directly in the diarthrodial joints of an individual's knees and used to restore the rheological properties of the synovial fluid that in turn produces an anti-inflammatory and analgesic effect. The standard hyaluronic acid and stabilized hyaluronic acid are prepared by sources including avian and non-avian origins. They are used to treat various osteoarthritides, such as knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis and are used by various end users such as hospitals, ambulatory surgical centers, and others.

What Is The Viscosupplementation Market Growth Forecast?

The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $7.34 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to adoption of regenerative medicine, integration of digital health monitoring, development of novel hyaluronic acid formulations, expansion of ambulatory surgical centers, rising investments in outpatient orthopedic procedures. Major trends in the forecast period include minimally invasive joint therapies, regenerative medicine integration, personalized osteoarthritis treatment, injectable hyaluronic acid innovations, outpatient orthopedic procedures.

Global Viscosupplementation Market Segmentation

1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation 2) By Source: Avian Origin, Non-Avian Origin 3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid 4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis 5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products, Non-Hyaluronic Acid Products 2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products 3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products

What Is The Driver Of The Viscosupplementation Market?

The rise in the prevalence of osteoarthritis is expected to propel the growth of the viscosupplementation market going forward. Osteoarthritis refers to a degenerative joint disease, also known as a common form of arthritis, in which the joints start to break down, mostly in the hips, knees, and hands. Viscosupplementation treatment helps to reduce pain and facilitate smooth bone movement by injecting hyaluronic acid straight into the bone joints, which enables a reduction in pain and improves the bone’s functionality. For instance, in August 2023, according to Institute for Health Metrics and Evaluation (IHME), a US-based nonprofit global health research center, reported that by 2050, osteoarthritis of the knee will increase by 75%, and osteoarthritis of the hand by 50%. Therefore, the rise in the prevalence of osteoarthritis is driving the growth of the viscosupplementation industry going forward.

Key Players In The Global Viscosupplementation Market

Major companies operating in the viscosupplementation market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd, Medtronic Inc.

Global Viscosupplementation Market Trends and Insights

Major companies operating in the viscosupplementation market are focused on developing innovative products such as resorbable, hyaluronic acid scaffolds to enhance joint lubrication, promote tissue regeneration, and provide long-lasting relief from osteoarthritis symptoms, thereby improving patient outcomes and expanding treatment options. A resorbable hyaluronic acid scaffold is a biocompatible, biodegradable structure made primarily from hyaluronic acid (HA), a naturally occurring polysaccharide found in connective tissues. For instance, in May 2023, Anika Therapeutics, Inc., a US-based company that offers orthopedics introduced Hyalofast, a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair. Hyalofast is designed to provide a hyaluronic acid-based solution aimed at joint preservation, potentially offering an alternative to more invasive surgical procedures.

What Are Latest Mergers And Acquisitions In The Viscosupplementation Market?

In August 2025, Ono Pharmaceutical Co., Ltd., a Japan-based provider of pharmaceuticals and medical products, partnered with Seikagaku Corporation for the co-development and marketing of Gel-One, a hyaluronic acid-based viscosupplement for osteoarthritis. With this partnership, the companies aim to expand their presence in the Japanese viscosupplementation market by combining Seikagaku’s product development and manufacturing capabilities with Ono’s marketing and distribution network. Seikagaku Corporation is a Japan-based developer and manufacturer of hyaluronic acid therapeutics, including injectable viscosupplements for joint health.

Regional Insights

North America was the largest region in the viscosupplementation market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viscosupplementation Market?

The viscosupplementation market consists of revenues earned by entities by providing viscosupplementation therapy services such as plasma-rich platelet (PRP) injections and stem cell injections that are used in osteoarthritis (OA) treatment procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation market also includes sales of hyaluronans and hylan injection preparations to provide viscosupplementation therapy services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Viscosupplementation Market Report 2026?

The viscosupplementation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viscosupplementation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.